DRKS00003251已完成2 期
Mobilization of CD34+ cells with standard or reduced dose filgrastim after vinorelbine in multiple myeloma patients. A randomized prospecitve single center phase II study. - ONK-USZ-002
niversität Zürich0 个研究点目标入组 60 人开始时间: 2011年9月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •All patients with multiple myeloma planned to undergo ASCT. Patients planned to receive vinorelbine for CD34+ cell mobilisation. No more than 1 induction chemotherapy (steroids only are allowed). Written informed consent.
排除标准
- •Known hypersensitivity or allergy to filgrastim (Neupogen®). Active Hepatitis B/C or HIV-infection. Treatment with other investigational products. Participation in another study with investigational drug. Inability to follow the procedures of the study. Known or suspected non-compliance. Drug or alcohol abuse. Pregnancy or breast feeding. Contraindications on ethical grounds.
研究者
相似试验
招募中
不适用
Effects of mobilisation of CD34-positive cells into the peripheral blood after Pegfilgrastim administration and their engraftment on post-transplantatioJPRN-UMIN000054037Hokkaido University Hospital50
已完成
1 期
Autologous peripheral blood-derived CD34+ cell transplantation for acute kidney injury.acute kidney injuryJPRN-UMIN000031691Kidney Disease and Transplant Center, Shonan Kamakura General Hospital9
已完成
不适用
G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with spinal cord injuries.Spinal cord injuryJPRN-UMIN000037388Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.6
已完成
不适用
G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with critical limb ischemia.Critical limb ischemia in patients undergoing hemodialysisJPRN-UMIN000037339Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.1
已完成
1 期
G-CSF mobilized CD34+ cell transplantation for hemodialysis patients with critical limb ischemia.peripheral arterial disease (critical limb ischemia)JPRN-UMIN000015266Shonan Kamakura General Hospital10